Only 13% survive this cancer. A blood test just detected 90% of early cases
A new blood-based diagnostic system shows potential in detecting early-stage pancreatic cancer, an area with historically low survival rates.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A whole-blood mRNA expression-based diagnostic system has been developed to identify early-stage pancreatic ductal adenocarcinoma. Clinical data indicates the test detected 90% of early-stage pancreatic cancers and can identify hidden cancer following treatment.
Coverage from Newsweek, Medical Xpress, and Nature emphasizes the test's diagnostic performance for stage 0-I pancreatic cancer. Clinical Lab Products and EurekAlert! have highlighted the study's findings, which were derived from a single-center case-control diagnostic accuracy study.
Future updates will depend on further validation of the diagnostic system's accuracy beyond the initial pilot study. Coverage does not yet specify a timeline for widespread clinical adoption or availability.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 8h ago.
Quick answers
What does the new blood test detect?
The test utilizes mRNA expression to detect early-stage pancreatic ductal adenocarcinoma and can identify hidden pancreatic cancer after treatment.
How effective is the test according to current studies?
Data indicates the system detected 90% of early-stage pancreatic cancers.
What is the survival rate for this cancer?
According to reports, the survival rate for this specific cancer is 13%.
Coverage (6)
- Blood test may detect pancreatic cancer before it is too late خبرگزاری آنا · 1d ago
- Blood Test Finds Hidden Pancreatic Cancer After Treatment Clinical Lab Products · 1d ago
- Blood gene test detects 90% of early-stage pancreatic cancers Medical Xpress · 1d ago
- Figure1. Diagnostic performance in stage 0-Ⅰ pancreatic cancer (IMAGE) EurekAlert! · 1d ago
- Pilot validation of a whole-blood mRNA expression-based diagnostic system for early-stage pancreatic ductal adenocarcinoma: a single-center case–control diagnostic accuracy study Nature · 1d ago
- Only 13% survive this cancer. A blood test just detected 90% of early cases Newsweek · 1d ago
Topics
Related trends
Kids with deadliest brain cancers survive years after breakthrough cell therapy
An experimental autologous T cell therapy has led to multi-year survival in children previously diagnosed with terminal brain cancer.
Prostate cancer treatment with fewer side effects 'as effective as radiotherapy and surgery'
A study suggests focal cryotherapy is as effective as surgery and radiotherapy for prostate cancer, offering patients fewer side effects.
A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses
A new experimental KRAS-targeted vaccine shows promise in early trials for preventing pancreatic cancer in high-risk individuals.
Alzheimer's blood test may predict who's likely to develop symptoms in 5 to10 years
New clinical studies suggest blood-based testing can identify Alzheimer’s disease risk in healthy adults up to a decade before symptom onset.
Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease
New clinical studies indicate blood tests may identify Alzheimer's disease risks in healthy individuals years before symptoms appear.
Can Ozempic prevent cancer? A doctor explains why the headlines are easy to misread
Recent research and medical commentary explore the evolving role of GLP-1 receptor agonists in oncology, sparking debate over their efficacy and risks.